Sandbox E20

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 14: Line 14:
The X-ray structure shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE, to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE versus butyrylcholinesterase (BChE). It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacological profiles.
The X-ray structure shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE, to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE versus butyrylcholinesterase (BChE). It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacological profiles.
- 
-
<scene name='90/902074/Zzz/3'>zzz_3</scene>
 
- 
-
<scene name='90/902074/Zzz/5'>zzz_5</scene>
 
- 
-
<scene name='90/902074/Zzz/6'>zzz_6</scene>
 
- 
-
<scene name='90/902074/Zzz/9'>zzz_9</scene>
 
- 
-
<scene name='90/902074/Zzz/8'>zzz_8</scene>
 
- 
-
<scene name='90/902074/W/1'>w</scene>
 
- 
-
<scene name='90/902074/V/1'>v</scene>
 
<scene name='90/902074/U/1'>u</scene>
<scene name='90/902074/U/1'>u</scene>

Revision as of 21:27, 20 January 2022

PDB ID 1eve

Drag the structure with the mouse to rotate

Reference

Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:10368299

Personal tools